Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib plus Gemcitabine/Carboplatin in Metastatic Triple-Negative Breast Cancer
NCT00540358Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in triple negative breast cancer (TNBC), sponsored by Sanofi. Started Oct 2007; status: completed.
02
Drugs
iniparib
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT00540358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540358.